Hyloris Pharmaceuticals SA is a specialty biopharmaceutical company dedicated to addressing unmet medical needs by innovating, reformulating, and repurposing existing medications
Hyloris Pharmaceuticals SA is a specialty biopharmaceutical company dedicated to addressing unmet medical needs by innovating, reformulating, and repurposing existing medications. The company leverages established regulatory pathways, such as the FDA’s 505(b)(2) in the U.S. and equivalents elsewhere, to optimize development timelines, reduce costs, and minimize risks for pharmaceuticals with proven safety and efficacy profiles. Hyloris has developed a broad proprietary portfolio of 19 valueadded